Sulotroban
| Sulotroban.svg | |
Sulotroban is a pharmacological agent that acts as a selective thromboxane receptor antagonist. It was developed for its potential therapeutic effects in conditions where thromboxane A2 (TXA2) plays a significant role, such as in cardiovascular diseases and thrombosis.
Pharmacodynamics[edit | edit source]
Sulotroban functions by inhibiting the action of thromboxane A2, a potent vasoconstrictor and promoter of platelet aggregation. By blocking the thromboxane receptor, sulotroban reduces platelet aggregation and vasoconstriction, which can be beneficial in preventing myocardial infarction and other thrombotic events.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of sulotroban includes its absorption, distribution, metabolism, and excretion. Sulotroban is administered orally and is absorbed through the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the kidneys.
Clinical Applications[edit | edit source]
Sulotroban has been investigated for use in various clinical settings, particularly in the prevention of thrombotic events in patients with cardiovascular risk factors. However, its clinical use has been limited due to the development of more effective agents and the complexity of thromboxane receptor pathways.
Research and Development[edit | edit source]
Research into sulotroban has provided insights into the role of thromboxane A2 in cardiovascular diseases. Although sulotroban itself is not widely used, it has paved the way for the development of other thromboxane receptor antagonists and has contributed to the understanding of platelet function and vascular biology.
Side Effects[edit | edit source]
The side effects of sulotroban are similar to those of other thromboxane receptor antagonists and may include gastrointestinal disturbances, headache, and dizziness. As with any medication affecting platelet function, there is a potential risk of bleeding.
Also see[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
